Positives

• Patients on CJC-1295 frequently describe improved sleep depth and gradual gains in recovery and body composition over 6-12 weeks.
  
  
• A patient reported that injecting at night turned the early-cycle drowsiness into an asset rather than a side effect.
  
  

Negatives

• Patients commonly report water retention, flushing, headache, and paradoxical fatigue in the first 2-4 weeks.
  
  
• One patient reported persistent fatigue that only resolved after dropping the dose, suggesting individual sensitivity to elevated GH pulses.
  
  

Hurdles & Side Effects

• CJC-1295 is not FDA-approved for human use in this manner; FDA reviews note adverse events including death across GH-secretagogue studies.
  
  
• Patients describe grey-market sourcing risk and inconsistent product quality from research-chemical vendors.